Read article: Very high-energy electrons could treat tumours deep within the body
Radiotherapy using beams of very high-energy electrons could treat large, deep-seated tumours while sparing healthy tissue
Read article: Gating and MLC tracking could increase access to real-time adaptive radiotherapy
Intrafraction motion adaptation strategies could make stereotactic ablative radiotherapy more accessible for prostate cancer patients
Read article: Boron neutron capture therapy is back on the agenda
Increasing commercial effort in developing boron neutron capture therapy facilities could bring this highly targeted cancer treatment into wider clinical use
Read article: Evidence for life is found on Venus, wider access to the best radiotherapy
We talk about reducing the global disparity in cancer treatment and Venusian phosphine
Read article: CERN accelerator technology to underpin FLASH radiotherapy facility
A collaboration between CERN and Lausanne University Hospital plans to use high-energy physics technologies to implement a clinical system for FLASH radiotherapy
Read article: Advanced radiotherapy – at a fraction of the cost
EmpowerRT aims to bring advanced radiotherapy technology to resource-limited cancer clinics in low- and middle-income countries at just 5–10% of the current cost
Read article: Focused X-ray beams provide personalized treatment for common eye disease
A radiotherapy technique based on X-ray focusing optics could improve the treatment of wet age-related macular degeneration
Read article: Fibre dosimeter could improve the accuracy of prostate cancer brachytherapy
An optical fibre dosimeter monitors the radiation dose received during prostate cancer brachytherapy
Read article: Acoustic imaging promises real-time dose measurement for FLASH radiotherapy
Exploiting the increased sound wave generation during FLASH radiotherapy could enable real-time monitoring of both the deposited dose and the patient’s anatomy
Read article: Caution required when balancing lung versus heart radiotherapy dose
Reducing cardiac dose at the expense of dose to the lungs might not always be a good strategy in oesophageal radiotherapy
